Clinical Trials

ID: 17-06-310-01
TITLE: Advanced Pancreatic Cancer TIGeR-PaC
SUMMARY:

People with Advanced Pancreatic Cancer are asked to participate in a research study being conducted by Montefiore Medical Center.

You may be eligible to participate in this study if you:

  • Are a least 18 years of age
  • Have confirmed diagnosis of pancreatic adenocarcinoma with initial diagnosis within the last 6 weeks
  • Have locally advanced, unresectable disease

You may not participate in this study if you:

  • Have had any prior treatment for pancreatic cancer
  • Have signs or symptoms of infection within 2 weeks prior to the first study treatment
  • Have a history of severe allergic, anaphylactic, or other hypersensitivity reactions to gemcitabine or nab-paclitaxel
  • Have uncontrolled seizures
  • Are pregnant or breastfeeding

 

Contact Information

Prena Etchen, Study Coordinator
1521 Jarrett Place
Bronx, NY 10461
Phone: (718) 379-6869
Email: pzagreda@montefiore.org

-